Genetic testing companies—including Ancestry and 23andMe—have agreed to new rules when it comes to sharing customers’ DNA with third-party companies, Fortune reported.

The global market for artificial intelligence (AI) in medical imaging is expected to see significant growth in the years ahead, topping $2 billion by 2023, according to a new report from Signify Research.

Genetic testing companies, including Ancestry and 23andMe, have agreed to new rules when it comes to sharing customers’ DNA with third-party companies.

Healthcare advocacy groups and other stakeholders are speaking out against the Trump administration’s decision to allow short-term healthcare insurance plans to extend up to three years.

More than 200 health services deals were reported in the second quarter of 2018, continuing the ongoing streak of mergers and acquisitions in the sector, according to PricewaterhouseCoopers.

Scientists have discovered a new type of cell—one that could radically change how researchers see cystic fibrosis. As part of a cellular mapping project, scientists identified a rare cell type that could affect rehydration and pH balance, which are integral to those with cystic fibrosis.

The stock price of health insurance giant Humana shot above $325 per share on Wednesday, August 2—a new record high—after its second-quarter earnings release.

Virginia launched a technology solution using its health information exchange, ConnectVirginia, to connect all the state's emergency departments to facilitate communication and collaboration among providers, healthcare plans and clinical and care management personnel.

Hospices will see a 1.8 percent, or $340 million, payment increase in 2019 after CMS finalized its annual payment update.

Bayer has shot back after a documentary aired on Netflix took aim its controversial birth control implant, Essure.